Published in Cancer Weekly, January 3rd, 2006
In a previous study, scientists in Texas "identified two thiazolidin compounds, 5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone (MMPT) and 5-(2,4-dihydroxybenzylidene)-2-(phenylimino)-1,3-thiazolidin (DBPT), that inhibit the growth of human nonsmall-cell lung and colon cancer cells independent of P-glycoprotein and p53 status."
In their subsequent study, F. Teraishi and coauthors at the University of Texas' M.D. Anderson Cancer Center "further investigated the mechanism by which these thiazolidin compounds mediate their anticancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.